Positive Preclinical Data on Mifcare’s MFC1040 for PAH Reported
News, Pulmonary Hypertension
Mifcare, a biotechnology company focused on research and development of drug candidates for the treatment of pulmonary hypertension, autoimmune inflammatory diseases and cancer, recently reported encouraging preclinical data for its ... Read more